These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6197036)

  • 21. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
    van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M
    Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
    Sedvall G; Fyrö B; Gullberg B; Nybäck H; Wiesel FA; Wode-Helgodt B
    Br J Psychiatry; 1980 Apr; 136():366-74. PubMed ID: 6155965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
    Garrick NA; Seppala T; Linnoila M; Murphy DL
    Eur J Pharmacol; 1985 Mar; 110(1):1-9. PubMed ID: 2408906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of propranolol on CSF amine metabolites in psychiatric patients.
    King DJ; Cooper SJ; Liddle J
    Br J Clin Pharmacol; 1983 Mar; 15(3):331-7. PubMed ID: 6189502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M; Chang WH; Kirk KL; Linnoila M
    Anal Biochem; 1983 May; 131(1):246-53. PubMed ID: 6193730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ; Leahey W; Green DF; King DJ
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    Thorén P; Asberg M; Bertilsson L; Mellström B; Sjöqvist F; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1289-94. PubMed ID: 6159865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
    Degrell I; Nagy E
    Biol Psychiatry; 1990 May; 27(10):1179-82. PubMed ID: 1692743
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):107-18. PubMed ID: 21644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE; Davenport Y; Cowdry RW; Webster MH; Goodwin FK
    Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.